pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Gene Therapy (AAV) · news · pharmadog
← back to Gene Therapy (AAV)
News · Gene Therapy (AAV)
221
stories
Jun 2, 26
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
fda press
Jun 1, 26
STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
stat
May 29, 26
Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks
biopharma dive
May 28, 26
Charles River CEO says it likely won’t be the last manufacturer to break away from cell and gene therapy
endpoints
May 19, 26
BioMarin drug acquired in buyout misses goal in rare disease study
biopharma dive
May 15, 26
STAT+: Top U.S. officials pressured Germany to pay more for prescription drugs
stat
May 14, 26
Makary’s departure and Cassidy’s tenuous Senate seat
stat
May 14, 26
#ASGCT26: Encoded's gene therapy reduced seizures in Dravet syndrome
endpoints
May 14, 26
STAT+: The hunt for FDA’s next leader
stat
May 14, 26
STAT+: BeOne wins FDA approval in lymphoma race
stat
May 14, 26
STAT+: Why big digital health players are missing from Medicare’s chronic care experiment
stat
May 14, 26
With new data, Regenxbio to seek FDA approval of Duchenne gene therapy
biopharma dive
May 14, 26
STAT+: Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage study
stat
May 14, 26
Regenxbio hits Duchenne gene therapy milestone, eyes 2027 FDA approval
endpoints
May 14, 26
STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
stat
May 14, 26
STAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission
stat
May 13, 26
#ASGCT26: After an apparent cure, a gene editing company struggles to repeat the magic
endpoints
May 13, 26
STAT+: What the Trump administration wants in its next FDA leader
stat
May 13, 26
U.S. overdose deaths fell again in 2025, but some worry about policy and drug supply changes
stat
May 13, 26
The ‘velocity of obesity’ aims to show which nations are slowing an epidemic
stat
May 13, 26
STAT+: Gene therapy viruses linked to a boy’s tumor
stat
May 13, 26
STAT+: Pharmalittle: We’re reading about FDA’s Makary resigning, a Lilly weight loss drug trial, and more
stat
May 13, 26
Extreme heat is worsening faster for Black Americans
stat
May 13, 26
STAT+: Drug meant to make gene therapy safer may also make it less effective
stat
May 13, 26
STAT+: Scientists link boy’s tumor to gene therapy viruses, in rare finding
stat
May 12, 26
STAT+: Why Marty Makary was the worst FDA commissioner in 25 years
stat
May 12, 26
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
biopharma dive
May 12, 26
STAT+: Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in
stat
May 12, 26
STAT+: Hims’ sales miss as telehealth competition grows
stat
May 12, 26
STAT+: Capsida says it still doesn’t know what caused gene therapy death
stat
← prev
page 6 of 8
next →
